Results 151 to 160 of about 1,025,401 (190)
Some of the next articles are maybe not open access.
Plasmapheresis in ABO incompatible kidney transplant
Transfusion and Apheresis Science, 2023In patients with an end-stage renal disease, dialysis a or kidney transplant are required to prolong live. For survival of the transplanted kidney, besides the HLA-system, the ABO blood type of donor and patient is also of importance. When the donor organ is derived from a living donor, time can be available prior to the transplant to reduce blood type
Hans, Vrielink, Kaatje, le Poole
openaire +2 more sources
ABO‐incompatible living kidney transplantation
Clinical Transplantation, 2020AbstractABO‐incompatible living kidney transplantation is nowadays a routine procedure to expand living donor pool. The past decades have seen the evolution of desensitization protocol and immunosuppression regimen. Despite increased bleeding events, infectious complications, and rejection episodes reported in some studies, favorable graft and patient ...
Menger Cen +5 more
openaire +2 more sources
ABO-incompatible kidney transplantation
Current Opinion in Organ Transplantation, 2012Purpose of review A dramatic shortage of available organs around the world encouraged attempts to cross previously forbidden immunological boundaries in kidney transplantation. This review focuses on the recent results of ABO-incompatible kidney transplantation.
Fehr T, Stussi G
openaire +3 more sources
ABO-Incompatible Kidney Transplantation
Transplantation, 2004When a renal transplant candidate's only medically-acceptable living kidney donor is ABO incompatible, the most common practice is to place them on the deceased donor list. Over the past few years, the implementation of paired kidney donor exchange programs and the development of protocols to overcome the ABO blood group barrier have become much more ...
Mark D, Stegall +2 more
openaire +2 more sources
ABO incompatible kidney transplantation
Current Opinion in Nephrology and Hypertension, 2007Although ABO incompatible kidney transplantation is increasingly recognized as effective, the procedure is still evolving. The purpose of this review is to summarize recent advances in this area.Short to intermediate-term outcome appears good, although long-term results are still preliminary.
James M, Gloor, Mark D, Stegall
openaire +2 more sources
ABO-Incompatible Kidney Transplantation and Rituximab
Transplantation Proceedings, 2005We have designed a protocol for ABO-incompatible kidney transplantations based on antigen-specific immunoadsorption rather than plasmapheresis to remove anti-A or anti-B antibodies and with a Prograf/Cellcept/prednisolone protocol using rituximab rather than splenectomy to prevent rebound antibodies.
G, Tydén +5 more
openaire +2 more sources
ABO Incompatible Kidney Transplantation in Children
Journal of Urology, 1995We have performed 7 pediatric kidney transplantations from living related donors of ABO incompatibility. All patients preoperatively underwent plasmapheresis with or without immunoadsorption to reduce anti-A and/or anti-B antibodies. Immunosuppression initially consisted of methylprednisolone, cyclosporine, azathioprine, antilymphocyte globulin and ...
Y, Yamazaki +5 more
openaire +2 more sources
Clinical Outcome of ABO-Incompatible Living Unrelated Donor Kidney Transplantation
<i>Background:</i> ABO-incompatible living unrelated donor kidney transplantation is an immunologically high-risk procedure, but few reports have been made on the outcomes of these transplants.
Junji Uchida +2 more
exaly +2 more sources
ABO‐incompatible kidney transplantation in children
Pediatric Transplantation, 2011Tydén G, Kumlien G, Berg UB. ABO‐incompatible kidney transplantation in children. Pediatr Transplantation 2011: 15: 502–504. © 2011 John Wiley & Sons A/S.Abstract: We designed a new protocol to enable safe ABO‐incompatible kidney transplantation. The new protocol utilizes antigen‐specific immunoadsorption rather than unspecific plasma exchange to
Gunnar, Tydén +2 more
openaire +2 more sources
Isoagglutinin Titers in ABO-Incompatible Kidney Transplant
Transplantation Proceedings, 2021A decrease in the isoagglutinin titer 1:128. We did not observe differences in patient survival: 96% vs 100% at 5 years (P = .64) and renal survival: 91% vs 100% at 5 years (P = .39), incidence of acute rejection: 13.2% vs 0% (P = .22), infectious complications (cytomegalovirus; 16% vs 30%, P = 0.30; Polyomavirus BK virus: 13% vs 0%, P = .22), or ...
Constantino Fernández Rivera +7 more
openaire +2 more sources

